By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > What Matters for Brain Health: Three Evidence-Based Magnesium Insights

What Matters for Brain Health: Three Evidence-Based Magnesium Insights

GMJ
Last updated: 25/06/2026 22:02
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Comparison chart showing different magnesium supplement forms and their cognitive research outcomes
New meta-analysis suggests total magnesium intake matters more than specific supplement forms for cognitive benefits. Long-term research shows no meaningful advantage for expensive formulations over basic magnesium salts. — Photo: Beelith USA / Pexels
SHARE
1 min read|150 words

New research provides clarity for patients and clinicians navigating the crowded magnesium supplement market. The evidence-based takeaway is straightforward: focus on total intake, not form.

First, long-term studies show no cognitive advantage for specific magnesium salts—whether citrate, L-threonate, or oxide. Second, brain imaging demonstrates that total magnesium consumption correlates with healthier gray matter and hippocampal volumes critical for memory function. The protective effects appear independent of which salt formulation delivers the magnesium.

Third, while head-to-head comparisons of different forms remain incomplete, current evidence suggests that consistent intake of any well-absorbed magnesium form at therapeutic doses provides comparable cognitive benefits. For practical purposes, this means patients need not invest in premium formulations; rather, selecting an affordable, bioavailable magnesium source and maintaining consistent intake offers the most benefit. Clinicians should counsel patients accordingly, emphasizing total dietary and supplemental magnesium intake over formulation marketing claims.

Read the full article on GMJ Newsroom.

Submit Your Paper
GMJ_Submit_Banner

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Magnesium Form May Not Matter for Cognitive Benefits, New Meta-Analysis Suggests →

Related reference
  • Magnesium · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Gene Therapy Shows Promise for Inherited Cholesterol Disorder in First-in-Human Trial

First-in-human gene therapy trial shows preliminary safety and efficacy for treating homozygous…

Teen Drug Use and Binge Drinking Linked to Severe Mental Health Crisis

UCLA research reveals dangerous links between teen substance use and mental health…

PFAS ‘Forever Chemicals’ Persist in Ski Wax Rooms Despite Regulatory Bans

New research reveals PFAS 'forever chemicals' persist in ski wax facilities years…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

EBOLA OUTBREAK – DRC/UGANDA CROSS-BORDER TRANSMISSION – WHO PHEIC DECLARED

By
Prof. Giorgi Pkhakadze
31/05/2026
Global HealthPolicy & Systems

Ebola Outbreak Spreads in Eastern DRC as Child Infections Expected to Spike

By
Prof. Giorgi Pkhakadze
15/06/2026

EBOLA OUTBREAK – CROSS-BORDER SPREAD DRC-UGANDA: WHO PHEIC DECLARATION

By
Prof. Giorgi Pkhakadze
31/05/2026
Medical students participating in virtual residency interviews on computer screens

NEJM Study: Virtual Residency Interviews Deliver Equal Selection Quality

By
Prof. Giorgi Pkhakadze
18/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up